Toggle navigation
About
Abstract
Editorial Board
Publication Schedule
Subscription & Newsletter
Contact
Issues
This issue
22-3
All issues
Download PDF
Download EPUB
Editor's Selection
This issue
22-3
Browse by topic
Browse by contributor
Dialogue & Opinion
Abstracts
Abstracts
Search
Classification List
Abstracted Journals
Index of Authors
News & Reports
Home
Abstracts
Index of Authors
Author #80772
advertisement
Lämmer R
16
Showing records 1 to 16 |
Display all abstracts from
Lämmer R
96361
Case Report: Neutralization of Autoantibodies Targeting G-Protein-Coupled Receptors Improves Capillary Impairment and Fatigue Symptoms After COVID-19 Infection
Hohberger B
Frontiers in medicine
2021; 8: 754667
95970
Blue-Yellow VEP with Projector-Stimulation in Glaucoma
Dussan Molinos L
Graefe's Archive for Clinical and Experimental Ophthalmology
2022; 260: 1171-1181
96142
Inhibitory and Agonistic Autoantibodies Directed Against the β-Adrenergic Receptor in Pseudoexfoliation Syndrome and Glaucoma
Hohberger B; Schlötzer-Schrehard U
Frontiers in neuroscience
2021; 15: 676579
95970
Blue-Yellow VEP with Projector-Stimulation in Glaucoma
Huchzermeyer C
Graefe's Archive for Clinical and Experimental Ophthalmology
2022; 260: 1171-1181
96361
Case Report: Neutralization of Autoantibodies Targeting G-Protein-Coupled Receptors Improves Capillary Impairment and Fatigue Symptoms After COVID-19 Infection
Harrer T; Mardin C
Frontiers in medicine
2021; 8: 754667
96142
Inhibitory and Agonistic Autoantibodies Directed Against the β-Adrenergic Receptor in Pseudoexfoliation Syndrome and Glaucoma
Mardin C
Frontiers in neuroscience
2021; 15: 676579
95970
Blue-Yellow VEP with Projector-Stimulation in Glaucoma
Lämmer R; Kremers J
Graefe's Archive for Clinical and Experimental Ophthalmology
2022; 260: 1171-1181
96142
Inhibitory and Agonistic Autoantibodies Directed Against the β-Adrenergic Receptor in Pseudoexfoliation Syndrome and Glaucoma
Lämmer R
Frontiers in neuroscience
2021; 15: 676579
96361
Case Report: Neutralization of Autoantibodies Targeting G-Protein-Coupled Receptors Improves Capillary Impairment and Fatigue Symptoms After COVID-19 Infection
Kruse F; Hoffmanns J
Frontiers in medicine
2021; 8: 754667
96142
Inhibitory and Agonistic Autoantibodies Directed Against the β-Adrenergic Receptor in Pseudoexfoliation Syndrome and Glaucoma
Munoz L
Frontiers in neuroscience
2021; 15: 676579
95970
Blue-Yellow VEP with Projector-Stimulation in Glaucoma
Horn FK
Graefe's Archive for Clinical and Experimental Ophthalmology
2022; 260: 1171-1181
96361
Case Report: Neutralization of Autoantibodies Targeting G-Protein-Coupled Receptors Improves Capillary Impairment and Fatigue Symptoms After COVID-19 Infection
Rogge L
Frontiers in medicine
2021; 8: 754667
96142
Inhibitory and Agonistic Autoantibodies Directed Against the β-Adrenergic Receptor in Pseudoexfoliation Syndrome and Glaucoma
Kunze R
Frontiers in neuroscience
2021; 15: 676579
96361
Case Report: Neutralization of Autoantibodies Targeting G-Protein-Coupled Receptors Improves Capillary Impairment and Fatigue Symptoms After COVID-19 Infection
Heltmann F
Frontiers in medicine
2021; 8: 754667
96142
Inhibitory and Agonistic Autoantibodies Directed Against the β-Adrenergic Receptor in Pseudoexfoliation Syndrome and Glaucoma
Herrmann M; Wallukat G
Frontiers in neuroscience
2021; 15: 676579
96361
Case Report: Neutralization of Autoantibodies Targeting G-Protein-Coupled Receptors Improves Capillary Impairment and Fatigue Symptoms After COVID-19 Infection
Moritz M; Szewczykowski C; Schottenhamml J; Kräter M; Bergua A; Zenkel M; Gießl A; Schlötzer-Schrehardt U; Lämmer R; Herrmann M; Haberland A; Göttel P; Müller J; Wallukat G
Frontiers in medicine
2021; 8: 754667
Issue
22-3
Table of Contents
Editor's Selection
PDF
EPUB
Change Issue
26-1
25-4
25-3
25-2
25-1
24-4
24-3
24-1/2
23-4
23-3
23-2
23-1
22-4
22-3
22-2
22-1
21-4
21-3
21-2
21-1
20-4
20-3
20-2
20-1
19-4
19-3
19-2
19-1
18-4
18-3
18-2
18-1
17-4
17-3
17-2
17-1
16-4
16-3
16-2
16-1
15-4
15-3
15-2
15-1
14-4
14-3
14-2
14-1
13-4
13-3
13-2
13-1
12-4
12-3
12-2
12-1
11-4
11-3
11-2
11-1
10-4
10-3
10-2
10-1
9-4
9-3
9-2
9-1
8-4
8-3
8-2
8-1
7-3
7-2
7-1
6-3
6-2
6-1
5-3
5-2
5-1
4-3
4-2
4-1
3-3
3-2
3-1
2-3
2-2
2-1
1-3
1-2
1-1
advertisement
We would like to use Google Analytics to see which parts of the review are read. It is only used to count visits, never for advertising.
Privacy statement
Decline
Accept